2018年筛选中心文章目录

2019年01月03日

2018年筛选中心文章目录[1] Pang Xiao-Cong#, Zhang Bao-Yue#, Mu Guang-Yan, Xia Jie, Xiang Qian, Zhao Xia, Liu Ai-Lin*, Du Guan-Hua*, Cui Yi-Min*. Screening of cytochrome P450 3A4 inhibitors via in silico and

2018年筛选中心文章目录

[1]    Pang Xiao-Cong#, Zhang Bao-Yue#, Mu Guang-Yan, Xia Jie, Xiang Qian, Zhao Xia, Liu Ai-Lin*, Du Guan-Hua*, Cui Yi-Min*. Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches. RSC Adv, 2018, 8, 34783-34792. ( 2017 IF 2.936)

[2]    Li Xu-Guang, Yuan Tian-Yi, Chen Di, Chen Yu-Cai, Sun Shu-Chan, Wang Dan-Shu, Fang Lian-Hua*, Yang Lu, Du Guan-Hua*. Cardioprotective effects of Puerarin-V on isoproterenol-induced myocardial infarction mice is associated with regulation of PPAR-γ/NF-κB pathway. Molecules, 2018, 23(12), 3322. (2017 IF:3.27)

[3]    Zheng Xiang-Jin#, Li Wan#, Ren Li-Wen, Liu Jun-Yi, Pang Xiao-Cong, Chen Xiu-Ping, Kang De, Wang Jin-Hua*, Du Guan-Hua*. The sphingosine kinase-1/ sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy. Pharmacol Ther. 2018 Oct 19. pii: S0163-7258(18) 30195-5. (2017 IF 10.376)有全文

[4]    Yang Xiu-Ying, Margaret C.L. Tse, Hu Xiang, Jia Wei-Hua, Du Guan-Hua*, Chan Chi-Bun*. Interaction of CREB and PGC-1α induces fibronectin type III domain-containing protein 5 expression in C2C12 myotubes. Cell Physiol Biochem. 2018 Oct; 50(4): 1574-1584. (2017 IF 5.5)

[5]     Song Jun-Ke, Zhang Wen, Wang Jin-Hua, Yang Hai-Guang, Zhao Xiao-Yue, Zhou Qi-Meng, Wang Hai-Gang, Li Li, Du Guan-Hua*. Activation of Nrf2 signaling by salvianolic acid C attenuates NF‑κB mediated inflammatory response both in vivo and in vitro. Int Immunopharmacol. 2018 Aug; 63: 299-310. (2017 IF 3.118)

[6]    Hou Bi-Yu, Zhao Yu-Rong, Qiang Gui-Fen, Yang Xiu-Ying, Xu Chun-Yang, Chen Xi, Liu Cheng-Ge, Wang Xiao-Bo, Zhang Li*, Du Guan-Hua*. Puerarin mitigates diabetic hepatic steatosis and fibrosis by inhibiting TGF-β signaling pathway activation in type 2 diabetic rats. Oxid Med Cell Longev. 2018 Jul 2; 2018:4545321. (2017 IF 4.936)

[7]    Pang Xiao-Cong#, Fu Wei-Qi#, Wang Jin-Hua, Kang De, Xu Lv-Jie, Zhao Ying, Liu Ai-Lin*, Du Guan-Hua*. Identification of estrogen receptor α antagonists from natural products via in vitro and in silico approaches. Oxid Med Cell Longev. 2018, 6040149. (2017 IF 4.936)

[8]    Wang Lin, Yu Zi-Ru, Ren Shu-Yue, Song Jun-Ke, Wang Jin-Hua, Du Guan-Hua*. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway. Biochim Biophys Acta. 2018 Oct, 1862(10): 2281-2292. (2017 IF:3.679)

[9]    Zhang Wen, Song Jun-Ke, Yan Rong, Li Li, Xiao Zhi-Yong, Zhou Wen-Xia, Wang Zhen-Zhong, Xiao Wei, Du Guan-Hua*. Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling. Acta Pharmacol Sin. 2018, 39: 1259-1272. (2017 IF 3.223)

[10]                                                 Li Chao, Xu Lv-Jie, Lian Wen-Wen, Pang Xiao-Cong, Jia Hao, Liu Ai-Lin*, Du Guan-Hua*. Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth. Acta Pharmacol Sin, 2018 (2017 IF 3.223)

[11] Li Wan#, Yi Jie#, Zheng Xiang-Jin, Liu Shi-Wei, Fu Wei-Qi, Ren Li-wen, Li Li, Hoon Dave SB, Wang Jin-Hua*, Du Guan-Hua*. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway. Clin Epigenetics. 2018 May 16; 10: 64. (2017 IF 6.091)

[12] Li Wan#, Liu Jin-Yi#, Fu Wei-Qi, Zheng Xiang-Jin, Ren Li-Wen, Liu S, Wang Jin-Hua*, Ji Teng-Fei*, Du Guan-Hua*. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. J Exp Clin Cancer Res. 2018 Jul; 37(1):132. (2017 IF 6.217)

[13] Yuan Tian-Yi, Niu Zi-Ran, Chen-Di, Chen Yu-Cai, Zhang Hui-Fang, Fang Lian-hua*, Du Guan-hua*. Vasorelaxant effect of quercetin on cerebral basilar artery in vitro and the underlying mechanisms study. J Asian Nat Prod Res, 2018 May; 20(5):477-487. (2017 IF:1.091)

[14] Zhang Wen, Song Jun-Ke, Zhang Xue, Zhou Qi-Meng, He Guo-Rong, Xu Xiao-Na, Yan Rong, Zhou Wen-Xia, Du Guan-Hua*. Salvianolic acid A attenuates ischemia reperfusion induced rat brain damage by protecting the blood brain barrier through MMP-9 inhibition and anti-inflammation. Chin J Nat Med. 2018 Mar; 16(3):184-193. (2017 IF 1.991)

[15] Qin Zhi-Zhen, Wang Shou-Bao, Lin Yi-Huang, Zhao Ying, Yang Sheng-Qian, Song Jun-ke, Xie Tao, Tian Jin-long, Wu Song, Du Guan-Hua*. Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice. Acta Pharm Sin B, 2018 Mar; 8(2): 306-315. (2017 IF:6.014)

[16] Wang Jin-Hua*, Li Wan, Zheng Xiang-Jin, Pang Xiao-Cong, Du Guan-Hua*. Research progress on the forkhead box C1. Oncotarget. 2018; 9(15): 12471-12478.

[17] Kang De, Pang Xiao-Cong, Lian Wen-Wen, Xu Lv-Jie, Wang Jin-Hua, Jia Hao, Zhang Bao-Yue, Liu Ai-Lin*, Du Guan-Hua*. Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches. RSC Adv, 2018, 8, 5286-5297. ( 2017 IF 2.936)

[18] Pang Xiao-Cong, Kang De, Fang Jian-Song, Zhao Ying, Xu Lv-Jie, Lian Wen-Wen, Liu Ai-Lin*, Du Guan-Hua*. Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to alzheimer's disease. Chin J Nat Med. 2018 Jan; 16(1): 53-62. (2017 IF 1.991)

[19] Cheng Xiao, Yang Ying-Lin, Yang Huan, Wang Yue-Hua*, Du Guan-Hua*. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway. Int Immunopharmacol. 2018 Mar; 56:29-35. (2017 IF 3.118)

[20] Lian Wen-Wen, Jia Hao, Xu Lv-Jie, Zhou Wei, Kang De, Liu Ai-Lin*, Du Guan-Hua*. Multi-protection of DL0410 in ameliorating cognitive defects in d-galactose induced aging mice. Front Aging Neurosci. 2017 Dec 8;9:409. doi: 10.3389/fnagi.2017.004092016 IF 4.504

[21] Pang Xiao-Cong, Zhao Ying, Wang Jing-Hua, Zhou Qi-Meng, Xu Lv-Jie, Kang De, Liu Ai-Lin*, Du Guan-Hua*. The bioinformatic analysis of the dysregulated genes and microRNAs in entorhinal cortex, hippocampus, and blood for Alzheimer's disease. Biomed Res Int. 2017:9084507. doi: 10.1155/2017/9084507. 2016 IF 2.476

[22] Wang Jin-Hua*, Li Wan, Zhao Ying, Kang De, Fu Wei-Qi, Zheng Xiang-Jin, Pang Xiao-Cong, Du Guan-Hua*. Members of FOX family could be drug targets of cancers. Pharmacol Ther. 2018; 181: 183-196. (2016 IF: 11.127)

[23] Zhang Bao-Yue#, Zheng Yi-Fu#, Pang Xiao-Cong#, Wang Zhe, Ding Hong, Liu Ai-Lin*. Network Pharmacologybased Study of the Active Constituents of Chinese Medicinal Formulae for Antitumor Mechanism. World J Tradit Chin Med, 2018, 4(2): 43-53. (2017 IF 0.857)

[24] 张宝月,郑一夫,庞晓丛,郑湘锦,王喆,丁虹,杜冠华*,刘艾林*。中药抗肿瘤作用的物质基础与网络机制研究。世界中医药,2018, 13(8): 1997-2009

[25] 张雯宋俊科,王海港,周启蒙,王晓波,杜冠华*。破壁灵芝孢子粉对环磷酰胺致小鼠免疫抑制的调节作用。食品与药品,2018, 20(6): 408-413

[26] 张雯,宋俊科,周启蒙,王海港,梁宇,杜冠华*。匹诺塞林对缺糖缺氧/复糖复氧诱导的SH-SY5Y细胞损伤的保护作用。中国新药杂志,2018, 27(22): 2651-2658

[27] 王晓波#,宋俊科#,张雯,于子茹,王海港,周启蒙,杜冠华*。全成分葡萄汁对D-半乳糖诱导小鼠的抗衰老作用。中国食物与营养,2018, 24(11), 64-73

[28] 贾伟华,杨秀颖*,杜冠华*。游离脂肪酸受体1对胰岛素分泌的调控作用及相关药物开发进展。药学学报,2018, 53(11), 1770-1777

[29] 陈熙,杨秀颖*,杜冠华*。尾加压素2型糖尿病能量代谢研究进展。中国药学杂志,2018, 53(22), 1885-1889

[30] 方莲花,杜冠华*。中药斑蝥毒的历史认识与评价。中药药理与临床,2018, 34(5): 150-152

[31] 杨秀颖,张雯,袁天翊,杜冠华*。中药鹤虱的历史认识与评价。中药药理与临床,2018, 34(5): 153-155

[32] 孔令雷,李莉,杜冠华*。中药急性子毒性的研究进展。中药药理与临床,2018, 34(5): 155-156

[33] 王霖,张雪,孔令雷,杜冠华*。仙茅等有小毒记载的祛风除湿中药毒性的历史认识与评价。中药药理与临床,2018, 34(5): 157-160

[34] 刘艾林,张莉,杜冠华*。闹羊花毒之历史认识与评价。中药药理与临床,2018, 34(5): 161-163

[35] 王金华,李莉,杜冠华*。中药天仙子的历史认识与评价。中药药理与临床,2018, 34(5): 163-165

[36] 杨海光,李莉,王月华,杜冠华*。中药朱砂毒的历史认识与评价。中药药理与临床,2018, 34(5): 165-167

[37] 于子茹,杜冠华*。乙酰胆碱α4β2型受体与抑郁症。药学学报,2018, 53(10): 1583-1590

[38] 杜冠华*,李莉,杨秀颖,张莉。中药毒之古今研究概况分析。中药药理与临床,2018, 34(4), 187-189

[39] 张莉,李莉,杜冠华*。中药马钱子毒的历史认识与现代研究。中药药理与临床,2018, 34(4), 191-194

[40] 杨海光,周启蒙,王海港,程笑,赵晓悦,吕扬,方莲花*,杜冠华*。晶V型芒果苷对高尿酸血症小鼠的作用及其机制研究。中国药理学通报,2018, 34(10): 1356-1362

[41] 孔令雷,马寅仲,李莉,陈燕霞,杜冠华*。脑卒中溶栓后出血转化的发生机制及治疗药物研究进展。药学学报,2018, 53(9): 14671476

[42] 宋俊科,张雯,张雪,王金华,杨海光,王喆,杜冠华。丹酚酸D通过抑制NF-κB的激活减轻LPS诱导的BV2细胞炎症反应。中国新药杂志,2018, 27(23): 105-111

[43] 宋俊科,张雯,张雪,王金华,杨海光,杜冠华。丹酚酸DMPP~+损伤SH-SY5Y细胞线粒体功能和生物合成的影响。中国药理学通报,2018, 34(9): 1211-1218

[44] 宋俊科,张雯,张雪,杨海光,周启蒙,王金华,杜冠华*。丹酚酸CMPP~+损伤的SH-SY5Y细胞氧化应激和凋亡的抑制作用。中国药理学与毒理学杂志,2018, 32(5): 392-399

[45] 程笑,杨滢霖,李伟瀚,王月华*,杜冠华*。秦皮甲素对LPS诱导小鼠急性肺损伤的作用及机制研究。中国新药杂志,2018, 27(16): 1849-1854

[46] 雷甜甜,刘艾林*,杜冠华*。欧美上市药物信息权威发布数据库及其应用。中国新药杂志,2018, 27(16): 1825-1829

[47] 周启蒙,赵晓悦,王海港,杨海光,宋俊科,王金华,杜冠华*。茶黄素降低高尿酸血症小鼠血清尿酸的作用与机制探究。中国新药杂志,2018, 27(14): 1631-1638

[48] 杜冠华*,张雯,杜立达,马寅仲,李莉,王月华。抗脑缺血药物研发现状分析与策略研究。神经药理学报,2018, 8(1): 1-8

[49] 李旭光,方莲花*,杜冠华*。黄酮类化合物的心血管保护作用机制研究进展。中国药理学通报,2018, 34(6): 741-744

[50] 许律捷,康德,贾皓,王金华,徐亚娟,张国印,杜新磊,刘艾林*,杜冠华*。二仙膏对环磷酰胺致白细胞减少症小鼠免疫功能的影响与免疫的初步研究。中国新药杂志,2018, 27(8), 940-947

[51] 陈颖,于浩滢,孙岚*,杜冠华*。血管平滑肌细胞表型转化中microRNA调控信号传导通路的研究进展。药学学报,2018, 53(4): 487-494

[52] 于子茹,李莉,王金华,王振中,萧伟,杜冠华*。桂枝茯苓胶囊原料药及其组分对人源乳腺癌细胞株增殖的影响。中国中西医结合杂志,2018, 38(2): 202-207

[53] 贾皓,庞晓丛,赵赢,王海港,刘艾林*,杜冠华*。远志治疗阿尔茨海默病的网络药理学作用机制。中国新药杂志,2018, 27(4): 398-404

[54] 杨欢,杨滢霖,程笑,邓安珺,秦海林,王月华*,杜冠华*。黄芩提取物对脂多糖诱导BV2细胞炎症反应作用及机制探讨。中国药学杂志,2018, 53(4): 268-272

[55] 杨滢霖,李伟翰,王月华*,杜冠华*。线粒体表观遗传修饰及药物靶点研究进展。中国新药杂志,2018, 27(1): 53-57

 

合作文章

[1]    Selma Houchi*, Rachid Mahdadi*, Abdelhalim Khenchouche, Song Jun-He, Zhang Wen, Pang Xiao-Cong, Zhang Li, Cemal Sandalli, Du Guan-Hua. Investigation of common chemical components and inhibitory effect on GES-type β-lactamase (GES22) in methanolic extracts of Algerian seaweeds. Microb Pathog. 2018 Oct; 126: 56-62.

[2]    Liu Jin-Yi, Zheng Xiang-Jin, Pang Xiao-Cong, Li Li, Wang Jin-Hua*, Yang Cui*, Du Guan-Hua*. Ganglioside GD3 synthase (GD3S), a novel cancer drug target. Acta Pharm Sin B. 2018 Sep; 8(5):713-720. 2017 IF 6.014

[3]    He Jun#, Xu Jie-Kun#, Pan Xue-Ge, Ye Xian-Sheng, Gao Pin-Yi, Yan Yu, Xu Chun-Yang, Qiang Gui-Fen, Du Guan-Hua, Cheng Yung-Chi, Zhang Wei-Ku*. Unusual cadinane-type sesquiterpene glycosides with α-glucosidase inhibitory activities from the fruit of Cornus officinalis Sieb. et Zuuc. Bioorg Chem. 2019, 82:1-5.

[4]    Chen Ken, Zhang Xiang-Lin, Ke Xiao-Yan, Du Guan-Hua, Yang Ke-Hu, Zhai Suo-Di*. Individualized medication of Voriconazole: A practice guideline of the division of therapeutic drug monitoring, Chinese Pharmacological Society. Ther Drug Monit. 2018 Sep 4. doi: 10.1097

[5]    Sun Jia-Lin, Song Jun-Ke, Zhang Wen, Jing Fan-Bo, Xu Wen, Leng Ping, Quan Xiang-Hua, Du Guan-Hua*, Sui Zhong-Guo*. Some pharmacokinetic parameters of salvianolic acid A following single-dose oral administration to rats. Pharm Biol. 2018 Dec; 56(1): 399-406. (有全文)

[6]    Liu Yue-tao*, Xu Wen-Qian, Xiong Yi-Feng, Du Guan-Hua, Qin Xue-Mei*. Evaluations of the effect of HuangQi against heart failure based on comprehensive echocardiography index and metabonomics. Phytomedicine. 2018 Nov; 50: 205-212.

[7]    Li Jia-Qi, Zhou Yu-Zhi, Du Guan-Hua, Qin Xue-Mei*, Gao Li*. Bioinformatic analysis reveals key genes and pathways in aging brain of senescence-accelerated mice P8 (SAMP8)`. CNS Neurol Disord Drug Targets. 2018 Aug 15. doi: 10.2174/1871527317666180816094741.

[8]    Zhao Fan-Fan, Gao Li, Qin Xue-Mei, Du Guan-Hua, Zhou Yu-Zhi*. The intervention effect of licorice in d-galactose induced aging rats by regulating the taurine metabolic pathway. Food Funct. 2018 Aug 22. doi: 10.1039/c8fo00740c.

[9]    Wang Xue#, Huang Hua#, Ma Xue-Ping, Wang Lin-Lin, Liu Chong, Hou Bi-Yu, Yang Sheng-Qian, Zhang Li*, Du Guan-Hua*. Anti-inflammatory effects and mechanism of the total flavonoids from Artemisia scoparia Waldst. et kit. in vitro and in vivo. Biomed Pharmacother. 2018 May;104: 390-403. (2016 IF: 2.759)

[10] Yang Xiu-Li, Chen Fei, Yang Xiu-Ying*, Du Guan-Hua, Xu Yang. Low molecular weight heparin does not reduce miscarriages in non-thrombophilic IVF/ICSI-treated women. Acta Obstet Gynecol Scand. 2018 Oct 14. doi: 10.1111/aogs.

[11] Yang Xiu-Li, Chen Fei, Yang Xiu-Ying*, Du Guan-Hua, Xu Yang. Efficacy of low-molecular-weight heparin on the outcomes of IVF/ICSI pregnancy in non-thrombophilic women: a meta-analysis. Acta Obstet Gynecol Scand. 2018 Sep; 97(9):1061-1072. (2017 IF: 2.649)

[12] Ma Yin-Zhong, Li Li, Kong Ling-Lei, Zhu Zhi-Mei, Zhang Wen, Song Jun-Ke, Chang Jun-lei*, Du Guan-Hua*. Pinocembrin protects blood-brain barrier function and expands the therapeutic time window for tissue-type plasminogen activator treatment in a rat thromboembolic stroke model. BioMed Res Int. 2018 Apr 22; 2018:8943210. doi: 10.1155/2018/8943210. (2016 IF: 2.476)

[13] Zhang Zhi-Hui, Yan Yu, Deng An-Jun, Zhang Hai-Jing, Li Zhi-Hong, Yuan Tian-Yi, Fang Lian-Hua, Wu Lian-Qiu, Du Guan-Hua, Qin Hai-Lin*. Synthesis of quaternary 8-(1-acylethene-1-yl)-13-methylcoptisine chlorides and their selective growth inhibitory activity between human cancer cell lines and normal intestinal epithelial cell-6. Chin Chem Lett, 2018 Jan; 29(1): 131-135. (2017 IF: 2.631)

[14] Wei State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Can-Jing, Xu State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Fang, Shi State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Meng-Jiao, Hu State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Jia-Wen, Wang State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Jia-Jia, Zhen State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Bo, Wang State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Xue, Ji State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Teng-Fei*, Wang Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Jin-Hua*, Du Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China Guan-Hua*. Synthesis and antitumor activities of sinomenine derivatives on rings A and C. J Asian Nat Prod Res, 2018, 20(3): 277-291. (2016 IF: 1.071)

[15] Zhao Fan-Fan, Chang Yan-Fen, Gao Li, Qin Xue-Mei*, Du Guan-Hua. Zhang Xiang, Zhou Yu-Zhi*. Protective effects of Scutellaria baicalensis Georgi extract on D-galactose induced aging rats. Metab Brain Dis. 2018 May 31. doi: 10.1007/s11011-018-0229-z. (2016 IF: 2.297)

[16] Gao Li*, Li Jia-Qi, Zhou Yu-Zhi, Huang Xu-Dong, Qin Xue-Mei*, Du Guan-Hua. The effects of baicalein on cortical pro-inflammatory cytokines and the intestinal microbiome in senescence accelerated mouse prone 8. ACS Chem Neurosci. 2018 Apr 18. doi: 10.1021/acschemneuro.8b00074. (2016 IF: 3.883)

[17] Liu Yue-Tao*, Xu Wen-Qian, Xiong Yi-Fen, Du Guan-Hua, Qin Xue-Mei*. Evaluations of the effect of Huangqi against heart failure based on comprehensive echocardiography index and metabonomics. Phytomedicine, 2018, (2016 IF: 3.526)

[18] Gao Li, Wang Ke-Xin, Zhou Yu-Zhi, Fang Jian-Song, Qin Xue-Mei*, Du Guan-Hua. Uncovering the anticancer mechanism of compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation. Sci Rep. 2018 Jan 12; 8(1):624. (2016 IF: 4.259)

[19] 陈修平,王金华,杜冠华*。川楝子毒的历史认识与现代研究。中药药理与临床,2018, 34(4), 189-191

[20] 贺晓丽,于蕾,杨秀颖,杜冠华*。中药牵牛子毒的历史考证与现代研究。中药药理与临床,2018, 34(4), 194-196

[21] 李玉娟,王月华,杜冠华*。中药雄黄毒的历史认识与现代研究。中药药理与临床,2018, 34(4), 196-198

[22] 徐春阳,李文兰,杨秀颖,强桂芬*,杜冠华*。脂肪代谢障碍与抗炎治疗策略。中药药理与临床,2018, 34(5), 168-172

[23] 徐春阳,李文兰*,杨秀颖,强桂芬,杜冠华。天然产物防治糖尿病周围神经病变的研究进展。中药药理与临床,2018, 34(4), 199-203

[24] 杨玉林,张雪,张雯,王海港,赵晓悦,宋俊科,王淑美,杜冠华*。百可利对氧化震颤素致小鼠震颤的抑制作用及其机制研究。中国新药杂志,2018, 27(8), 914-920

[25] 姚阳阳,刘晓宇,杨飞龙,杨 颖,袁天翊,方莲花,杜冠华,焦晓臻*,谢 *。新型Rho激酶抑制剂的设计、合成及生物活性评价。有机化学,2018, 38(4): 871-882

[26] 蒋宁,齐春会,曹亮,陈兰英,顾金辉,康永,Inkyeom KIM,连晓媛,陆茵,吕圭源,聂克,齐云,Valérie SCHINI-KERTHMichael SPEDDINGCherry WAINWRIGHT,王月华,肖伟,杨勇,余林中,张丹参,张永鹤,周文霞,杜冠华*,张永祥*。新形势·新策略——中药新药及健康产品研发与国际化发展。中国药理学与毒理学杂志,2018, 32(1): 1-50

[27] 王玉敏,葛永利,赵丽楠,杜冠华*,王洪权*。虾青素的神经保护作用机制研究进展。中国药学杂志,2018, 53(8): 569-573

[28] 王玉敏,葛永利,赵丽楠,赵伟丽,杜冠华*,王洪权*。异硫氰酸酯在实验性帕金森病中神经保护作用的研究进展。中国药学杂志,2018, 53(5): 325-329

[29] 王玉敏,葛永利,赵丽楠,赵伟丽,杜冠华*,王洪权*。匹诺塞林的神经保护作用机制研究进展。中国药学杂志,2018, 53(4): 245-248

[30] 宋再伟,谈志远,李幼平,杜冠华,张相林,翟所迪,赵荣生*。应用德尔菲法确定大剂量甲氨蝶呤临床用药指南的临床问题与结局指标。药物流行病学杂志,2018, 22(2): 134-138

[31] 武彩霞,杜冠华*。匹诺塞林对脑缺血再灌注内质网应激凋亡相关基因mRNA表达的影响。中国临床药理学与治疗学,2018, 23(1): 34-40

[32] 王英,龚宁波*,杨德智,杜冠华,吕扬*。顺丁烯二酸文拉法辛的制备与表征及稳定性。医药导报,2018, 37(9): 1099-1102。(国家重点研发计划(2016YFC1000901) ; 中国医学科学院医学与健康科技创新工程项目( 2017I2M-1-010)

[33] 张娜,张雯,庾莉菊,吕扬*,杜冠华。非洛地平及其制剂的晶型分析。中国药学杂志,2018, 53(1): 64-71

[34] 张宝喜,张丽,龚宁波,吕扬*,杜冠华*2种异烟肼共晶的结构分析及Hirshfeld表面分析。医药导报,2018, 37(1): 12-15

[35] 卢紫娟,刘海霞,李昆,秦正国,秦雪梅,杜冠华,朱平*,李震宇*。基于网络药理学的脑震宁颗粒治疗脑外伤的机制分析。中草药,2018, 49 (15): 3531-3540

[36] 史静超,张俊杰,高晓霞,张斌,秦雪梅*,杜冠华*。龟龄集胶囊无机元素指纹图谱的建立及主成分分析。中草药,2018, 49 (15): 3619-3624

[37] 李晓霞,王迪,王桂臻,李震宇,秦雪梅,杜冠华,李科*。基于内切-1,4-β-半乳聚糖酶水解的黄芪糖指纹图谱的建立及不同种质资源黄芪的鉴别。中药材,2018, 41 (6): 1306-1311

[38] 高四云,李科*,秦雪梅*,李震宇,李爱平,刘月涛,杜冠华,张翔。基于绝对生长年限野生与移栽黄芪质量比较研究。中草药,2018, 49 (10): 2248-2257

[39] 李佳琪,高丽*,王珂欣,周玉枝,秦雪梅*,杜冠华。快速老化小鼠SAMP8模型粪便代谢物和肠道菌群改变的研究。中草药,2018, 49 (10): 2265-2273

[40] 王迪,刘磊,李科*,李爱平,刘月涛,秦雪梅,杜冠华,张翔。基于内切-1,3-β-葡聚糖酶水解的黄芪糖指纹图谱的建立及不同种质资源黄芪鉴别。中草药,2018, 49 (10): 2320-2327

[41] 王迪,李科*,王桂臻,李震宇,秦雪梅,杜冠华,张翔。基于内切-1,4-β-甘露聚糖酶水解的黄芪糖指纹图谱的建立及不同种质资源黄芪鉴别。中国中药杂志,2018, 43(14): 2964-2972

[42] 张瑞,李科*,李爱平,何盼,秦雪梅*,张翔,杜冠华。基于~1HNMR技术黄芪抗疲劳作用的肌肉代谢组学研究。药学学报,2018, 53 (5): 782-790

[43] 薛立英,高丽,秦雪梅,杜冠华,周玉枝*。汉黄芩苷通过调节抗氧化基因表达和机体代谢延长果蝇寿命。中国生物化学与分子生物学报,2018, 34(4): 404-416

[44] 贺晶,高晓霞,田俊生,秦雪梅,杜冠华,周玉枝*UPLC-MS背景扣除法联合代谢组学技术分析柴胡-白芍药对配伍前后化学成分变化。中草药,2018, 49(8): 1779-1788

[45] 贺晶,高晓霞,田俊生,秦雪梅,杜冠华,周玉枝*UPLC-MS分析柴胡、白芍水煎液的化学成分及其对逍遥散的贡献。山西医科大学学报,2018, 49(4): 375-382

[46] 高四云,李科*,熊一峰,秦雪梅*,崔贵梅,张翔,杜冠华。恒山仿野生黄芪绝对生长年限鉴别及黄酮和皂苷积累规律研究。药学学报,2018, 53 (1): 147154

[47] 曹俊姿,杨德智,张丽,杜冠华,吕扬*。左炔诺孕酮优势药用晶型研究。医药导报,医药导报,2017, 36(12): 1339-1343。(17年未收录)

[48] 张峰,秦雪梅,杜冠华,高晓霞*。抗抑郁药物的体内代谢研究进展。药学学报,2017, 52(12): 1791-1800。(17年未收录)

[49] 李震宇*,段亚辉,秦雪梅*,杜冠华*。中药质量差异性研究的思考。药学学报,2017, 52(12): 1820 -1826。(17年未收录)

[50] 庞溢媛,薛立英,郑艳红,周玉枝*,秦雪梅,杜冠华,张翔。基于UHPLC-MS/MS代谢组学技术的不同采收期黄芩质量比较研究。药学学报, 2017, 52(12): 1903-1909